BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28193280)

  • 1. Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.
    Inoue H; Hashimura M; Akiya M; Chiba R; Saegusa M
    Mol Cancer; 2017 Feb; 16(1):37. PubMed ID: 28193280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
    Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
    BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug.
    Saegusa M; Hashimura M; Kuwata T; Okayasu I
    Am J Pathol; 2009 Jun; 174(6):2107-15. PubMed ID: 19389926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.
    Tochimoto M; Oguri Y; Hashimura M; Konno R; Matsumoto T; Yokoi A; Kodera Y; Saegusa M
    Lab Invest; 2020 May; 100(5):682-695. PubMed ID: 31857700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the alpha-1 type II collagen gene by nuclear factor B/p65 and Sox9 in the chondrocytic phenotype of uterine carcinosarcomas.
    Yoshida T; Hashimura M; Kuwata T; Matsumoto T; Suzuki E; Tazo Y; Nakajima H; Inukai M; Saegusa M
    Hum Pathol; 2013 Sep; 44(9):1780-8. PubMed ID: 23618358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
    Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
    Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation.
    Chiba R; Akiya M; Hashimura M; Oguri Y; Inukai M; Hara A; Saegusa M
    PLoS One; 2017; 12(8):e0183516. PubMed ID: 28837676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene alterations in endometrial carcinosarcomas.
    Biscuola M; Van de Vijver K; Castilla MÁ; Romero-Pérez L; López-García MÁ; Díaz-Martín J; Matias-Guiu X; Oliva E; Palacios Calvo J
    Hum Pathol; 2013 May; 44(5):852-9. PubMed ID: 23199529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
    Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
    BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
    Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1.
    Voena C; Varesio LM; Zhang L; Menotti M; Poggio T; Panizza E; Wang Q; Minero VG; Fagoonee S; Compagno M; Altruda F; Monti S; Chiarle R
    Oncotarget; 2016 May; 7(22):33316-30. PubMed ID: 27119231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.
    Kobayashi Y; Yokoi A; Hashimura M; Oguri Y; Konno R; Matsumoto T; Tochimoto M; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
    Am J Pathol; 2023 Aug; 193(8):1116-1128. PubMed ID: 37169340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
    Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
    Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.
    Pelosi G; Gasparini P; Conte D; Fabbri A; Perrone F; Tamborini E; Pupa SM; Ciravolo V; Caserini R; Rossi G; Cavazza A; Papotti M; Nakatani Y; Maisonneuve P; Pastorino U; Sozzi G
    J Thorac Oncol; 2016 May; 11(5):718-728. PubMed ID: 26804638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
    Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of E-cadherin and β-catenin in uterine carcinosarcoma.
    Nishimura I; Ohishi Y; Oda Y; Kishimoto J; Yasunaga M; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Virchows Arch; 2011 Jan; 458(1):85-94. PubMed ID: 21046151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma.
    Zhang J; Wang P; Wu F; Li M; Sharon D; Ingham RJ; Hitt M; McMullen TP; Lai R
    Cell Signal; 2012 Apr; 24(4):852-8. PubMed ID: 22155737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; ; Merino MJ; Mutch DG; Goodfellow PJ; Mullikin JC; Bell DW
    Cancer; 2018 Jan; 124(1):65-73. PubMed ID: 28940304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic and molecular features of uterine carcinosarcomas.
    Lopez-Garcia MA; Palacios J
    Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Molecular Characterization of Uterine Carcinosarcoma.
    Cherniack AD; Shen H; Walter V; Stewart C; Murray BA; Bowlby R; Hu X; Ling S; Soslow RA; Broaddus RR; Zuna RE; Robertson G; Laird PW; Kucherlapati R; Mills GB; ; Weinstein JN; Zhang J; Akbani R; Levine DA
    Cancer Cell; 2017 Mar; 31(3):411-423. PubMed ID: 28292439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.